References
- Voskaridou E, Terpos E, Spina G, et al. Pamidronate is an effective treatment for osteoporosis in patients with beta thalassemia. Br J Haematol 2003;123:730–737.
- Domrongkitchaiporn S, Sirikulchayananonta V, Angchaisuk-siri P. Abnormalities in bone mineral density and bone histology in thalassaemia. J Bone Mineral Res 2003; 18:1682–1690.
- Pollak RD, Rachmilewita E, Blumenfeld A. Bone mineral metabolism in adults with 3-thalassemia major and inter-media. Br J Haematol 2000;111: 902–907.
- Voskaridou E, Kyrtsonis MC, Terpos E, et al. Bone resorption is increased in young adults with thalassemia major. Br J Haematol 2001;112:36–41.
- Morabito N, Lasco A, Gaudio A, et al. Bisphosphanates in the treatment of thalassemia induced osteoporosis. Osteoporo Int 2002;13:644–649.
- Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, et al. Bone mineral density of patients with thalassemia major: Four-year follow-up. Calcif Tissue Int 1999;64:481–484.
- De Sanctis V. Growth and puberty and its management in thalassemia. Horm Res 2002;58(Supp. 1):72–79.
- Dandona P, Monor RK, Houlder S, et al. Serum 1,25 dihydroxy vitamin D and osteocalcin concentrations in thalassemia major. Arch Dis Childhood 1987;62:474–477.
- Shalitin S, Carmi D, Weintrob N, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol 2005;74:93–100.
- Yilmaz N, Bayram M, Erbagci AB, et al. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis. Chin Chem Lab Med 1999;37(2):137–143.
- Power MJ, Fottrell PF. Osteocalcin: Diagnostic methods and clinical applications. Crit Rev Chin Lab Sci 1991;28(4): 287–335.
- Morabito N, Gaudio A, Lasco A, et al. Osteoprotegerin and RANKL in the pathogenesis of thalassemia induced osteo-porosis: New pieces of the puzzle. J Bone Mineral Res 2004;19 (5):722–728.
- Yilmaz N, Pence S, Kepekci Y, et al. Association of immune function with bone mineral density and biochemical markers of bone turnover in patients with ankylosing spondylitis. Int J Chin Pract 2003;57(8):681–685.
- Bielinski BK, Darbyshire PJ, Mathers L, et al. Impact of disordered puberty on bone density in 3-thalassemia major. Br J Haematol 2003;120:353–358.
- Caro JJ, Huybrechts KF, Green TC, et al. Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: A systematic review. BMC Blood Disorders 2002;2 (4):1–9.
- Jensen CE, Tuck SM, Old J, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with 3-thalassemia. Eur J Hematol 1997;9:76–81.
- Mahachoklertwattana P, Chuansumrit A, Choubtum L, et al. Bone mineral density in children and young adults with 13-thalassemia trait. J Pediatr Endocrinol Metab 2002;15: 1531–1535.
- Stefano MD, Chiabotto P, Roggia C, et al. Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. J Bone Mineral Metab 2004;22:53–57.
- Eren E, Yilmaz N. Biochemical markers of bone turnover and bone mineral density in patients with 3-thalassemia major. Int J Clin Pract 2005;59(1):46–51.
- Moulas A, Challa A, Chaliasos N, et al. Vitamin D metabolites (25-hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in P-thalassemia. Acta Pediatr 1997;86:594–599.
- Soliman AT, Banna EI, Abdel Fattah M. Bone mineral density in prepubertal children with beta-thalassemia: Correlation with growth and hormonal data. Metabolism 1998; 47:541–548.
- Mahachoklertwattana P, Chuansumrit A, Sirisriro R, et al. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with 13-thalas-semia disease. Chin Endocrinol 2003;58:273–279.
- Sartorio A, Conte G, Conti A, et al. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassemia major. J Endocrinol Investig 2000;23:356–361.
- Finkelestein JS, Neer RM, Biller BM, et al. Osteopenia in men with a history of delayed puberty. N Eng J Med 1992;326:600–604.
- Lasco A, Morabito N, Gaudio A, et al. Effects of hormonal replacement therapy on bone metabolism in young adults with beta thalassemia major. Osteoporosis Int 2001;12:570–575.
- Garofalo F, Piga A, Lala R, et al. Bone metabolism in thalassaemia. Ann NY Acad Sci 1998;850:475–478.